Get your early-bird registration to AusBiotech 2018
More than 1000 delegates are expected to attend AusBiotech 2018, to be held from 31 October – 2 November at the Brisbane Convention & Exhibition Centre, Queensland.
A strong contingent of delegates is expected from the Asia Pacific region, USA and Europe. Register now to secure substantial early-bird savings.
Get your early-bird registration here.
Dr Charmaine Gittleson
Chief Medical Officer, CSL Limited
Dr Gittleson is an internationally experienced pharmaceutical physician, having worked in the biopharmaceutical industry for over 20 years. She joined CSL in 2005, initially based in Australia where she established a clinical safety and then a clinical development function.
From 2010 to 2017 Dr Gittleson was based in King of Prussia, Pennsylvania, USA, where she was responsible for CSL’s clinical development strategy and ultimately all global clinical research. She has overseen the clinical development of both seasonal and pandemic influenza vaccines as well as a number of biologics within the rare disease and orphan ‘space’, resulting in global registrations. Additionally, she has experience establishing new R&D groups in Japan and China.
Since returning to Melbourne, Australia, in 2017, Dr Gittleson has assumed the global role of Chief Medical Officer for CSL Limited. In this capacity she has responsibility for early development and oversees the benefit–risk profile of CSL products across their life cycle.
Mr John Carroll
Editor in Chief, Endpoints
Mr Carroll is a biotech analyst with 38 years of prize-winning experience in journalism. Aside from his daily industry coverage for FierceBiotech, where he was editor from 2003-2016, Mr Carroll has been a regular speaker at biotech events around the globe. He’s been quoted by The New York Times, The New Yorker, Financial Times, and more. He’s also keynoted at biotech gatherings around the world and addressed student audiences at MIT and Harvard.
Mr Carroll has covered genomics, biotechnology, healthcare and other business topics for American Banker, Managed Care and many other publications. He has contributed stories from Central America and Ireland to The Dallas Morning News and Time and has written for the Houston Press.
Mr Carroll spent six years as editor and publisher of the Dallas Business Journal, was publisher of Texas Business, and early in his career was part of a Pulitzer Prize-winning team of reporters and editors at The Kansas City Star & Times.
Millis Oration – Professor Doug Hilton
Institute Director Division Head of Molecular Medicine, Walter & Eliza Hall Institute
As the Millis Orator, Professor Hilton will be discussing the three pillars of WEHI’s activities – science, translation and entrepreneurship.
Professor Hilton is a biologist interested in understanding blood cell production and function, and how cells communicate with each other. As the Director of the Institute since 2009, his priorities have included strengthening the governance framework; overseeing the $185 million renovation and extension of research facilities; expanding the Institute’s translational research capacities; maximising collaborative opportunities in research, education and clinical care with partners; and ensuring Australian medical research is administered and funded in smart and strategic ways.
The Millis Oration is named after Emeritus Professor Nancy Millis (1922-2012), who is recognised as the First Lady of biotechnology.